Latest filing published 06 May 2026 for Croda International Plc, €59k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Stephen Edward Foots: trading record in brief
Stephen Edward Foots is a declared insider of Croda International PLC, with filings sourced from RNS (LSE). In total, 17 filings cover trades dated from 12 May 2017 to 5 May 2026.
The open-market side counts 2 purchases for €115k alongside 10 sales for €36.0M. Taken together, the sales exceed the purchases by €35.9M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 5 share grants. 2026 to date brings no purchases and 2 sales.
The newest entry dates from 6 May 2026: an open-market sale of €59k, in Croda International PLC. The clock since the last published purchase (4 August 2025) now reads 462 days. The median gap between a trade and its publication by RNS (LSE) is 1 day. The legal deadline for notifying a trade is three business days (UK MAR). Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by RNS (LSE) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Stephen Edward Foots
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 224 shares@ £228.400.0014% mcap0.4% of flowXLONISIN GB00BJFFLV09RNS:f56e0c14-68b7-478d-891c-0c5a1d835a07
- 11,300 shares@ £130.31124.7% of flowXLONISIN GB00BJFFLV09RNS:ee105cd3-07de-419f-ba90-1d39f34b09ba
- 3,815 shares@ £26.16810.8% of flowXLONISIN GB00BJFFLV09RNS:5766458Canonical exit: 2 Nov 2025 (T+90)
- 10,137 shares@ £128.09674.3% of flowXLONISIN GB00BJFFLV09RNS:5588427
- 4,061 sharesN/A - Grant of a Conditional AwardISIN GB00BJFFLV09RNS:5167763
- 13,327 shares@ £79.905226.1% of flowXLONISIN GB00BJFFLV09RNS:5120337
- 138 shares@ £38.980.0% of flowXLONISIN GB00BJFFLV09FCA-NSM:4603188
- 43,107 shares@ £121.351220.3% of flowXLONISIN GB00BJFFLV09FCA-NSM:4305731
- 173 shares@ £41.440.0% of flowXLONISIN GB00BJFFLV09FCA-NSM:4162283
- 174 shares@ £30.920.0% of flowXLONISIN GB00BJFFLV09FCA-NSM:3918913
- 24,628 shares@ £126.86711.1% of flowXLONISIN GB00BJFFLV09FCA-NSM:3914504
- 27,243 shares@ £50.12881.3% of flowXLONISIN GB00BJFFLV09FCA-NSM:3607561
- 44 shares@ £0.020.0% of flowXLONISIN GB00BJFFLV09FCA-NSM:3559574Canonical exit: 8 Jul 2020 (T+90)
- 74,437 shares@ £132.502248.3% of flowXLONISIN GB00BYZWX769FCA-NSM:LSE20190306100155_13992176_20200326185134386_25877
- 102 shares@ £17.630.0% of flowXLONISIN GB00BYZWX769FCA-NSM:LSE20180426155741_13620589_20200330111351376_2803
- 66,155 shares@ £78.238643.6% of flowXLONISIN GB00BYZWX769FCA-NSM:LSE20180308111837_13559891_20200330111427784_23212
- 30,450 shares@ £76.634920.8% of flowXLONISIN GB00BYZWX769FCA-NSM:LSE20170515165657_13226094_20200330131531017_11681
17 of 17 declarations